| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $18.0B | $17.9B | $18.9B | $19.8B | $20.7B | $5.1B | $5.2B | $5.4B |
| Cost of Revenue | $15.0B | $14.8B | $15.6B | $16.3B | $17.3B | $15.2B | $17.5B | $18.4B |
| Gross Profit | $3.0B | $3.1B | $3.4B | $3.6B | $3.4B | $0.8B | $0.9B | $0.9B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $2.8B | $2.8B | $3.1B | $3.0B | $2.8B | $2.6B | $2.7B | $2.8B |
| Operating Income | $0.2B | $0.3B | $0.3B | $0.6B | $0.6B | $0.1B | $0.2B | $0.2B |
| Net Income | $-0.0B | $0.1B | $0.1B | $0.4B | $0.4B | $0.1B | $0.1B | $0.6B |
| EPS (Basic) | $-0.29 | $3.04 | $1.78 | $7.17 | $7.01 | $1.34 | $2.35 | $2.56 |
| EPS (Diluted) | $-0.29 | $3.01 | $1.76 | $7.08 | $6.91 | $1.33 | $2.33 | $2.54 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $9.2B | $8.2B | $8.8B | $9.1B | $9.8B | $9.3B | $9.2B | $8.5B |
| Current Assets | $5.8B | $5.0B | $5.6B | $5.9B | $6.4B | $6.7B | $6.5B | $6.0B |
| Cash & Equivalents | $0.9B | $0.5B | $0.6B | $0.6B | $0.8B | $1.6B | $1.0B | $0.6B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $5.2B | $4.4B | $4.8B | $4.9B | $5.8B | $4.7B | $4.4B | $4.2B |
| Stockholders' Equity | $2.1B | $2.1B | $2.2B | $2.4B | $2.5B | $2.4B | $2.7B | $2.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $-0.1B | $0.3B | $0.3B | $0.4B | $0.6B | $0.9B | $0.8B | — |
| Investing Cash Flow | $-0.1B | $-0.1B | $-0.1B | $-0.1B | $-1.0B | $-0.0B | $-0.0B | — |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $0.5B | $-0.3B | $-0.3B | $-0.5B | $-0.3B | $-0.4B | $-0.3B | — |